Evidence map›Paper›PMID 31623305›Full record

ReviewInternational journal of molecular sciences2019

Impact of Carcinogenic Chromium on the Cellular Response to Proteotoxic Stress.

Leonardo M R Ferreira, Teresa Cunha-Oliveira, Margarida C Sobral, Patrícia L Abreu, Maria Carmen Alpoim, Ana M Urbano

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 53 citations in OpenAlex.

  1. Chromium as a Risk Factor for Breast Cancer: A Meta-Analysis.Asian Pacific journal of cancer prevention : APJCP · 2022
    Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Nrf2/cyclooxygenase 2 signaling in Cr(VI)-induced carcinogenesis.Ecotoxicology and environmental safety · 2025
    Article
  7. Article
  8. Article
  9. Review
  10. Plants (Basel, Switzerland) · 2023
    Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Cr(VI) reduction and adsorption by bimetallic nanoparticles from Li-ion batteries.Environmental science and pollution research international · 2020
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Leonardo M R FerreiraDepartment of Surgery and Diabetes Center and Sean N. Parker Autoimmune Research Laboratory, University of California, San Francisco, San Francisco, CA 94143, USA. leonardo.ferreira@ucsf.edu.ORCID 0000-0003-2491-9866
Teresa Cunha-OliveiraCNC-Center for Neuroscience and Cell Biology, University of Coimbra, UC-Biotech, Biocant Park, 3060-197 Cantanhede, Portugal. teresa.oliveira@uc-biotech.pt.ORCID 0000-0002-7382-0339
Margarida C SobralDepartment of Life Sciences, University of Coimbra, 3000-456 Coimbra, Portugal. margaridasobral2014@hotmail.com.ORCID 0000-0002-6255-5584
Patrícia L AbreuInstituto de Medicina Molecular João Lobo Antunes, Faculty of Medicine, University of Lisbon, 1649-028 Lisbon, Portugal. patricia.abreu@medicina.ulisboa.pt.
Maria Carmen AlpoimDepartment of Life Sciences, Center of Investigation in Environment, Genetics and Oncobiology (CIMAGO) and CNC-Center for Neuroscience and Cell Biology, University of Coimbra, 3000-456 Coimbra, Portugal. mcalpoim@gmail.com.
Ana M UrbanoDepartment of Life Sciences, Molecular Physical Chemistry Research Unit and Center of Investigation in Environment, Genetics and Oncobiology (CIMAGO), University of Coimbra, 3000-456 Coimbra, Portugal. amurbano@ci.uc.pt.
University of Coimbra · PTBiocant · PTUniversity of California, San Francisco · USUniversity of Lisbon · PT

Funding

CIMAGO 16/12Fundação para a Ciência e a Tecnologia (FCT, Portugal) UID/Multi/00070/2019, RH/BPD/101169/2014, PD/BD/128284/2017, SFRH/BD/91614/2012, POCI-01-0145-FEDER-029297, PTDC/MAR-BIO/6149/2014
6 · The paper itself

Abstract

Worldwide, several million workers are employed in the various chromium (Cr) industries. These workers may suffer from a variety of adverse health effects produced by dusts, mists and fumes containing Cr in the hexavalent oxidation state, Cr(VI). Of major importance, occupational exposure to Cr(VI) compounds has been firmly associated with the development of lung cancer. Counterintuitively, Cr(VI) is mostly unreactive towards most biomolecules, including nucleic acids. However, its intracellular reduction produces several species that react extensively with biomolecules. The diversity and chemical versatility of these species add great complexity to the study of the molecular mechanisms underlying Cr(VI) toxicity and carcinogenicity. As a consequence, these mechanisms are still poorly understood, in spite of intensive research efforts. Here, we discuss the impact of Cr(VI) on the stress response-an intricate cellular system against proteotoxic stress which is increasingly viewed as playing a critical role in carcinogenesis. This discussion is preceded by information regarding applications, chemical properties and adverse health effects of Cr(VI). A summary of our current understanding of cancer initiation, promotion and progression is also provided, followed by a brief description of the stress response and its links to cancer and by an overview of potential molecular mechanisms of Cr(VI) carcinogenicity.

Indexed as

Carcinogens, EnvironmentalCell Transformation, NeoplasticChromiumDNA DamageHumansNeoplasmsOxidative StressStress, PhysiologicalCarcinogens, EnvironmentalChromiumcarcinogenesisheat shock proteinshexavalent chromiumHSP70HSP90HSP inhibitoroccupational lung carcinogenproteotoxic stressstress responseunfolded protein response

Identifiers

PMID31623305
PMCPMC6801751
OpenAlexW2978598141

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.